Final - February 18, 2016

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

page 1 of 2

PURPOSE PRESIDER/PRESENTER(s)

8:00 Dr. Nancy Bennett (ACIP Chair)

Dr. Amanda Cohn (ACIP Executive Secretary;

CDC)

8:15 Agency Updates

CDC, CMS, DoD, DVA, FDA, HRSA, IHS, NIH, NVPO Information CDC and ex officio members

8:30 Human Papillomavirus (HPV) Vaccines

Introduction

Background: 2-dose schedules 

9-valent HPV vaccine 2- vs 3-dose trial data 

Summary: 2-dose schedules, bivalent and quadrivalent 

HPV vaccines 

Work Group plans

Dr. Allison Kempe (ACIP, WG Chair)

Dr. Lauri Markowitz (CDC/NCIRD)

Dr. Alain Luxembourg (Merck)

Dr. Lauri Markowitz (CDC/NCIRD)

Dr. Elissa Meites (CDC/NCIRD)

9:50 Break

10:20 Meningococcal Vaccines

Introduction

MenB-FHbp vaccine update

Results of a mass immunization campaign with MenB-4C in 

Quebec, Canada

Considerations for use of MenACWY vaccines in HIV-infected 

persons 

Meningococcal disease among men who have sex with men 

(MSM), United States, January 2012-June 2015

Considerations for use of MenACWY vaccines in MSM 

Dr. Lorry Rubin (ACIP, WG Chair)

Dr. Laura York (Pfizer)

Dr. Gaston De Serres (Quebec, Canada)

Ms. Jessica MacNeil (CDC/NCIRD)

Dr. Temi Folaranmi (CDC/NCIRD)

Ms. Jessica MacNeil (CDC/NCIRD)

12:10 Lunch

1:20 Japanese Encephalitis (JE) Vaccine

Introduction

Duration of protection following primary series and booster 

dose in adults

Duration of protection and need for booster dose in children 

JE Vaccine Work Group summary and plans

Dr. Lorry Rubin (ACIP, WG Chair)

Dr. Katrin Dubischar (Valneva)

Dr. Katrin Dubischar (Valneva)

Dr. Susan Hills (CDC/NCEZID)

Dr. Ruth Karron (ACIP, WG Chair)

Ms. Lynnette Brammer (CDC/NCIRD)

Dr. Wayne Hachey (Protein Sciences)

Dr. John Kelso (University of California, San 

Diego)

Dr. Lisa Grohskopf (CDC/NCIRD)

2:10 Influenza

Introduction

Influenza surveillance update

Quadrivalent Recombinant Influenza Vaccine

Influenza Vaccination and Egg Allery 

Vote

3:10 Break

3:30 Update on Zika Virus Dr. Toby Merlin (CDC/NCEZID)

Information & 

Discussion 

Information & 

Discussion

Information & 

Discussion

Information, 

Discussion

Proposed Recommendations for 2016-17

Welcome & Introductions

Wednesday, February 24 

 

Centers for Disease Control and Prevention

1600 Clifton Road, NE, Tom Harkin Global Communications Center, Kent "Oz" Nelson Auditorium

Atlanta, Georgia 30329 

AGENDA ITEM

February 24, 2016 (1-day meeting)
Final - February 18, 2016

page 2 of 2

3:40 Cholera Vaccine

Introduction

VaxchoraTM clinical data 

Cholera Vaccine GRADE evaluation and Work Group plans

Dr. Art Reingold (ACIP, WG Chair)

Dr. Lisa Danzig (PaxVax)

Dr. Karen Wong (CDC/NCEZID)

4:50 Vaccine Supply Dr. Jeanne Santoli (CDC/NCIRD)

4:55 Public Comment

5:10 Adjourn

Acronyms

CDC

CMS

DoD

DVA

FDA

GRADE

HRSA

IHS

LAIV

MSM

NCHHSTP

NCIRD

NCEZID

NIH

NVPO

VFC

WG

Men who have sex with men

CDC National Center for Immunization & Respiratory Diseases [of CDC/OID] 

Live Attenuated Influenza Vaccine

Work Group

National Center for HIV, Hepatitis, STD and TB Prevention [of CDC/OID] 

Vaccines for Children

Health Resources and Services Administration

Indian Health Service

Department of Defense

National Institutes of Health

National Vaccine Program Office

National Center for Emerging and Zoonotic Diseases [of CDC/OID]

Grading of Recommendations Assessment, Development and Evaluation

Centers for Medicare and Medicaid Services 

Centers for Disease Control & Prevention

Food and Drug Administration

Department of Veterans Affairs

Information & 

Discussion